Clinical trial
Multi-center, Randomized, Double Blinded, Phase III Trial to Assess the Immunogenicity and Safety of NBP606 in Adults 50 Years of Age and Older Who Are naïve to Pneumococcal Vaccine
NCT02079207 is registered in ClinicalTrials.gov with SK Chemicals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Randomized, Double Blinded, Phase III Trial to Assess the Immunogenicity and Safety of NBP606 in Adults 50 Years of Age and Older Who Are naïve to Pneumococcal Vaccine
- Lead sponsor
- SK Chemicals Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- March 31, 2015
- Enrollment
- 767 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.